IRIS
DAVID, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.378
AS - Asia 2.933
EU - Europa 1.787
SA - Sud America 341
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 4
Totale 8.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.294
SG - Singapore 1.174
CN - Cina 827
IE - Irlanda 362
VN - Vietnam 359
IT - Italia 275
BR - Brasile 263
SE - Svezia 251
FI - Finlandia 242
HK - Hong Kong 220
DE - Germania 198
UA - Ucraina 172
TR - Turchia 116
BD - Bangladesh 104
NL - Olanda 88
FR - Francia 75
ZA - Sudafrica 75
CA - Canada 63
RU - Federazione Russa 41
GB - Regno Unito 39
IN - India 25
AR - Argentina 24
EC - Ecuador 17
IQ - Iraq 17
UZ - Uzbekistan 15
BE - Belgio 12
ES - Italia 10
VE - Venezuela 10
PH - Filippine 9
CL - Cile 8
PK - Pakistan 8
MX - Messico 7
PL - Polonia 7
TH - Thailandia 7
TN - Tunisia 7
ID - Indonesia 6
LB - Libano 6
JO - Giordania 5
JP - Giappone 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
AT - Austria 4
CO - Colombia 4
JM - Giamaica 4
KR - Corea 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EG - Egitto 3
KE - Kenya 3
OM - Oman 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PA - Panama 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.551
Salva come PNG Salva come JPEG
Città #
Singapore 568
Ashburn 379
Dublin 360
Chandler 347
San Jose 331
Santa Clara 328
Jacksonville 303
Hong Kong 211
Beijing 202
Council Bluffs 117
Ho Chi Minh City 111
Izmir 106
Boardman 92
San Mateo 92
Nanjing 87
Dearborn 82
Hanoi 79
Princeton 77
Johannesburg 71
Ann Arbor 64
Lauterbourg 64
Los Angeles 59
Wilmington 50
Toronto 46
New York 44
Hebei 42
Dallas 41
Parma 41
Shenyang 40
Jinan 35
Shanghai 33
Helsinki 32
Moscow 32
Buffalo 27
Tianjin 24
Columbus 23
Kunming 23
Nanchang 23
Haiphong 22
São Paulo 21
Bologna 20
Changsha 19
Bremen 16
Jiaxing 15
Munich 15
Tashkent 15
Woodbridge 15
Des Moines 13
Hefei 13
Seattle 13
Zhengzhou 13
Genoa 12
Brussels 11
Da Nang 11
Guangzhou 11
Haikou 10
Rome 10
Norwalk 9
Nuremberg 9
Atlanta 8
Brooklyn 8
Frankfurt am Main 8
Phoenix 8
San Francisco 8
Chengdu 7
Hangzhou 7
Houston 7
Hải Dương 7
Montreal 7
Stockholm 7
The Dalles 7
Turku 7
Warsaw 7
Baghdad 6
Brasília 6
Fuzhou 6
Goiânia 6
Ningbo 6
Taiyuan 6
Can Tho 5
Caxias do Sul 5
Chicago 5
Duncan 5
Guayaquil 5
Kyiv 5
Lima 5
London 5
Napoli 5
Ninh Bình 5
Rio de Janeiro 5
Rockville 5
Amman 4
Auburn Hills 4
Bangkok 4
Belo Horizonte 4
Biên Hòa 4
Borås 4
Buenos Aires 4
Denver 4
Dhaka 4
Totale 5.214
Salva come PNG Salva come JPEG
Nome #
IL PROGETTO PIRP (PREVENZIONE INSUFFICIENZA RENALE PROGRESSIVA) DELLA REGIONE EMILIA-ROMAGNA: ANALISI DEI RISULTATI PRELIMINARI 226
CALCIFICASSI ESITATA IN GUARIGIONE DOPO TERAPIA CON TIOSOLFATO 167
Burnout in health care providers of dialysis service in Northern Italy—a multicentre study 156
HEMOFILTRATION AND HEMODIAFILTRATION REDUCEINTRADIALYTIC HYPOTENSION IN ESRD 153
CLINICAL POLICIES ON THE MANAGEMENT OF CHRONIC KIDNEY DISEASE PATIENTS IN ITALY 148
IMPROVEMENT OF INTRADIALYTIC TOLERANCE WITH LOW VOLUME DIALYSIS AND BICARBONATE BUFFERING OF DIALYSATE. 146
2-h DIALYSIS: A REALISTIC GOAL ? 138
ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION INDUCES PROINFLAMMATORY ACTIVITY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS. 137
EFFECTS OF ADD-ON FLUVASTATIN THERAPY IN PATIENTS WITH CHRONIC PROTEINURIC NEPHROPATHY ON DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE: THE ESPLANADE TRIAL 137
CLINICAL EFFECTS OF ONLINE DIALYSATE AND INFUSION FLUIDS 135
A SIMPLE APPROACH FOR ASSESSING EQUILIBRATED KT/VB2M ON A ROUTINE BASIS. 135
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 135
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results 134
ADHERENCE OF HUMAN MONOCYTES TO HAEMODIALYSIS MEMBRANES 134
ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT BY CULTURED HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS 134
Albumin loss in on-line haemodiafiltration 133
Bacterial contamination of the dialysis fluid in different dialyzing machines 133
THE SIGNIFICANCE OF THE HBeAG/ANTI HBe SYSTEM IN HEMODIALYSISPATIENTS. A MULTICENTER STUDY. 132
Aliskiren Combined with Losartan in Type 2 Diabetesand Nephropathy 131
STORIA E PRINCIPI BIOFISICI GENERALI DELLE TECNICHE CONVETTIVE 128
HEMOFILTRATION: PREDILUTION VERSUS POSTDILUTION 128
BASIC THERAPEUTIC REQUIREMENTS IN THE TREATMENT OF SEPSIS IN ACUTE RENAL FAILURE 127
BEHAVIOUR OF B2-MICROGLOBULIN REMOVAL WITH DIFFERENT DIALYSIS SCHEDULES 126
ADEQUACY OF TREATMENT OF UREMIA IN THE NINETIES 126
GLUCOSE METABOLISM AND LARGER MOLECULE REMOVAL IN LONG-TERM HIGH-EFFICIENCY HEMOFILTRATION 124
Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion 122
Variable radiological lung nodule evaluation leads to divergent management recommendations 122
An overview of hemodialysis and oxidant stress 120
A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis 120
Sarcoid granulomatous nephritis with isolated and reversible renal failure. A case report. 115
ASSOCIAZIONE TRA LIVELLI DI ACIDO URICO E RISCHIO DI PROGRESSIONE DELL’INSUFFICIENZA RENALE O DI MORTE PER OGNI CAUSA 115
Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis 114
CYCLOSPORIN A AND DRUG INTERACTION. 114
ROLE OF PLATELET ACTIVATING FACTOR IN HEMODIALYSIS. 113
PRESENTAZIONE DI UNA FORMULA PER IL CALCOLO IMMEDIATO DEL KT/V DELLA BETA2 MICROGLOBULINA 113
L'emodialisi e la dialisi peritoneale 112
CORRECTION OF UREMIC ACIDOSIS BY HEMODIALYSIS 110
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change 109
DANGER OF UNNECESSARILY PROLONGED DIALYSIS SESSION: CARPAL TUNNEL SYNDROME 106
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. 105
PRE-POSTDILUTION HEMOFILTRATION 105
Organic contamination in dialysis water: trichloroethylene as a model compound. 105
Alterations of the cytokine network in hemodialysis 105
REVERSIBLE ACUTE CYCLOSPORINE NEPHROTOXICITY INDUCED BY COLCHICINE ADMINISTRATION 105
Tolerance to ultrafiltration in hemodialysis 104
Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC). 102
Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes 100
IL REBOUND E IL KT/V EQUILIBRATO DELLA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 100
Disinfection in dialysis, using aldehydes. Theoretical considerations and practical use 99
Long-term outcome and clinical significance of orthostatic proteinuria. 98
Urea in Exhaled Breath Condensate of Uraemics and Patients with Chronic Airway Diseases 98
Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial 98
THE EMILIA-ROMAGNA REGION PIRP PROGRAMME ( PREVENTION IN PROGRESSION OF PROGRESSIVE RENAL INSUFFICIENCY) 95
Preventing the epidemic of cardiovascular disease: new perspectives in extracorporeal substitutive treatment 94
IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC). 94
THE HEMATOPOIETIC SYSTEM IN RENAL FAILURE 92
TERAPIA CON CALCIFEDIOLO NEI PAZIENTI CON CKD E DEFICIT DI VITAMINA D. 92
Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS 92
EFFETTI DELLA TERAPIA PROLUNGATA CON CALCITRIOLO SU FGF23 E SUL METABOLISMO CALCIO-FOSFORICO NELL’IRC. 92
Dialysis strategies 90
Immunological aspects of urinary tract infections 87
TANDEM PLASMA-EXCHANGE (PE) DIALYSIS. UNA VARIANTE SEMPLIFICATA. 87
Contribution of echotomography (ET) to transcutaneous renal needle-biopsy (RNB) and to the detection of possible complications 86
COMPARISON OF 3 AUTOMATED ASSAYS FOR C-REACTIVE PROTEIN IN END-STAGE RENAL DISEASE: CLINICAL AND EPIDEMIOLOGICAL IMPLICATIONS 85
PRODUCTION OF PLATELET ACTIVATING FACTOR BY HUMAN NEUTROPHILS AFTER BACKFILTRATION OF ENDOTOXIN CONTAMINATED DIALYSATE. 85
Renal insufficiency (RI) evolving to a definitive cure in sarcoidosic granulomatous nephritis (SGN) 85
RISULTATI DELL’ECOCARDIOGRAFIA ESOFAGEA E TRANSTORACICA IN PAZIENTI IN EMODIALISI SENZA CARDIOPATIE CLINICAMENTE RILEVANTI 84
EFFETTI A MEDIO TERMINE DEL CALCITRIOLO NEI PAZIENTI CON INSUFFICIENZA RENALE CRONICA E IPERPARATIROIDISMO LIEVE-MODERATO 84
THE COST/BENEFIT RATIO OF RENAL REPLACEMENT THERAPY 83
Determination of urinary albumin excretion in subclinical forms of glomerulonephritis by electroimmunodiffusion. 82
QUANTIFICAZIONE DELL’EFFICIENZA DIALITICA PER L’UREA E PER LA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 82
HEMOFILTRATION-INDUCED SERUM MODIFICATIONS IN THE PATTERN OF LARGER MOLECULES 81
THE ROLE OF PLATELET-ACTIVATING FACTOR IN THE BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES 80
PREDILUTION HEMOFILTRATION. CLINICAL EXPERIENCE AND REMOVAL OF SMALL MOLECULAR WEIGHT SOLUTES 80
IN VITRO AND IN VIVO BIOCOMPATIBILITY OF SUBSTITUTED CELLULOSE AND SYNTHETIC MEMBRANES 74
THE ROLE OF ADSORPTION IN 2-MICROGLOBULIN REMOVAL 72
SARCOID GRANULOMATOUS NEPHRITIS WITH ISOLATED AND REVERSIBLE RENAL FAILURE. A CASE REPORT. 70
Totale 8.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022357 0 1 9 6 10 7 51 62 19 47 39 106
2022/20231.243 143 110 78 82 109 151 5 75 441 3 28 18
2023/2024326 29 56 12 9 37 67 0 29 9 15 25 38
2024/20251.607 33 89 95 43 194 286 7 65 217 153 125 300
2025/20262.870 272 246 309 164 463 171 349 61 396 234 138 67
2026/2027156 47 109 0 0 0 0 0 0 0 0 0 0
Totale 8.560